Minimally invasive image-guided therapies for hepatocellular carcinoma

Mohamed E Abdelsalam,1 Ravi Murthy,1 Rony Avritscher,1 Armeen Mahvash,1 Michael J Wallace,1 Ahmed O Kaseb,2 Bruno C Odisio,1 1Department of Interventional Radiology, 2Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: Hepatocellular...

Full description

Bibliographic Details
Main Authors: Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/minimally-invasive-image-guided-therapies-for-hepatocellular-carcinoma-peer-reviewed-article-JHC
_version_ 1818906036472381440
author Abdelsalam ME
Murthy R
Avritscher R
Mahvash A
Wallace MJ
Kaseb AO
Odisio BC
author_facet Abdelsalam ME
Murthy R
Avritscher R
Mahvash A
Wallace MJ
Kaseb AO
Odisio BC
author_sort Abdelsalam ME
collection DOAJ
description Mohamed E Abdelsalam,1 Ravi Murthy,1 Rony Avritscher,1 Armeen Mahvash,1 Michael J Wallace,1 Ahmed O Kaseb,2 Bruno C Odisio,1 1Department of Interventional Radiology, 2Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: Hepatocellular carcinoma (HCC) is the fifth most frequently occurring cancer globally and predominantly develops in the setting of various grades of underlying chronic liver disease, which affects management decisions. Image-guided percutaneous ablative or transarterial therapies have acquired wide acceptance in HCC management as a single treatment modality or combined with other treatment options in patients who are not amenable for surgery. Recently, such treatment modalities have also been used for bridging or downsizing before definitive treatment (ie, surgical resection or liver transplantation). This review focuses on the use of minimally invasive image-guided locoregional therapies for HCC. Additionally, it highlights recent advancements in imaging and catheter technology, embolic materials, chemotherapeutic agents, and delivery techniques; all lead to improved patient outcomes, thereby increasing the interest in these invasive techniques. Keywords: hepatocelleular carcinoma, locoregional therapy, TACE, ablation, 90Y
first_indexed 2024-12-19T21:32:50Z
format Article
id doaj.art-fe7d1d2c241640e1a162e171552a318f
institution Directory Open Access Journal
issn 2253-5969
language English
last_indexed 2024-12-19T21:32:50Z
publishDate 2016-10-01
publisher Dove Medical Press
record_format Article
series Journal of Hepatocellular Carcinoma
spelling doaj.art-fe7d1d2c241640e1a162e171552a318f2022-12-21T20:04:52ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692016-10-01Volume 3556129401Minimally invasive image-guided therapies for hepatocellular carcinomaAbdelsalam MEMurthy RAvritscher RMahvash AWallace MJKaseb AOOdisio BCMohamed E Abdelsalam,1 Ravi Murthy,1 Rony Avritscher,1 Armeen Mahvash,1 Michael J Wallace,1 Ahmed O Kaseb,2 Bruno C Odisio,1 1Department of Interventional Radiology, 2Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: Hepatocellular carcinoma (HCC) is the fifth most frequently occurring cancer globally and predominantly develops in the setting of various grades of underlying chronic liver disease, which affects management decisions. Image-guided percutaneous ablative or transarterial therapies have acquired wide acceptance in HCC management as a single treatment modality or combined with other treatment options in patients who are not amenable for surgery. Recently, such treatment modalities have also been used for bridging or downsizing before definitive treatment (ie, surgical resection or liver transplantation). This review focuses on the use of minimally invasive image-guided locoregional therapies for HCC. Additionally, it highlights recent advancements in imaging and catheter technology, embolic materials, chemotherapeutic agents, and delivery techniques; all lead to improved patient outcomes, thereby increasing the interest in these invasive techniques. Keywords: hepatocelleular carcinoma, locoregional therapy, TACE, ablation, 90Yhttps://www.dovepress.com/minimally-invasive-image-guided-therapies-for-hepatocellular-carcinoma-peer-reviewed-article-JHCHepatocelleular Carcinoma – Locoreginal therapy – TACE – Ablation –Y90
spellingShingle Abdelsalam ME
Murthy R
Avritscher R
Mahvash A
Wallace MJ
Kaseb AO
Odisio BC
Minimally invasive image-guided therapies for hepatocellular carcinoma
Journal of Hepatocellular Carcinoma
Hepatocelleular Carcinoma – Locoreginal therapy – TACE – Ablation –Y90
title Minimally invasive image-guided therapies for hepatocellular carcinoma
title_full Minimally invasive image-guided therapies for hepatocellular carcinoma
title_fullStr Minimally invasive image-guided therapies for hepatocellular carcinoma
title_full_unstemmed Minimally invasive image-guided therapies for hepatocellular carcinoma
title_short Minimally invasive image-guided therapies for hepatocellular carcinoma
title_sort minimally invasive image guided therapies for hepatocellular carcinoma
topic Hepatocelleular Carcinoma – Locoreginal therapy – TACE – Ablation –Y90
url https://www.dovepress.com/minimally-invasive-image-guided-therapies-for-hepatocellular-carcinoma-peer-reviewed-article-JHC
work_keys_str_mv AT abdelsalamme minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT murthyr minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT avritscherr minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT mahvasha minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT wallacemj minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT kasebao minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma
AT odisiobc minimallyinvasiveimageguidedtherapiesforhepatocellularcarcinoma